Foretinib Is Effective against Triple-Negative Breast Cancer Cells MDA-MB-231 In Vitro and In Vivo by Down-Regulating p-MET/HGF Signaling

This study investigated the antitumor effects of foretinib on triple-negative breast cancer cells MDA-MB-231 xenograft tumors in vivo underlying phosphorylated mesenchymal to epithelial transition (p-MET)/ hepatocyte growth factor (HGF)-related mechanism, as well as its pharmacokinetic characteristi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Xiwei, Meng, Xiangrui, He, Qingfeng, Xiang, Xiaoqiang, Shi, Yufei, Zhu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821162/
https://www.ncbi.nlm.nih.gov/pubmed/36614199
http://dx.doi.org/10.3390/ijms24010757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821162/
https://www.ncbi.nlm.nih.gov/pubmed/36614199
http://dx.doi.org/10.3390/ijms24010757

Ejemplares similares